Neuberger Berman Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $236K | Sell |
|
|||||
|
2024
Q3 | $312K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $4.9M | Buy |
|
|||||
|
2023
Q4 | $3.34M | Sell |
|
|||||
|
2023
Q3 | $4.74M | Buy |
|
|||||
|
2023
Q2 | $4.74M | Buy |
|
|||||
|
2023
Q1 | $2.75M | Buy |
|
|||||
|
2022
Q4 | $1.84M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2.12M | Sell |
|
|||||
|
2020
Q4 | $3.41M | Sell |
|
|||||
|
2020
Q3 | $2.22M | Buy |
|
|||||
|
2020
Q2 | $1.56M | Sell |
|
|||||
|
2020
Q1 | $977K | Buy |
|